Skip to Content
MilliporeSigma

T0240000

Testosterone decanoate

European Pharmacopoeia (EP) Reference Standard

Synonym(s):

17β-Hydroxy-4-androsten-3-one 17-decanoate, 4-Androsten-17β-ol-3-one 17-caprate

Slide 1 of 1
Sign In to View Organizational & Contract Pricing

Select a Size

60 MG

$133.60

$133.60

List Price$167.00Save 20%
Check Cart for Availability
Request a Bulk Order

About This Item

Empirical Formula (Hill Notation):
C29H46O3
CAS Number:
5721-91-5
Molecular Weight:
442.67
MDL number:
MFCD00133847
UNSPSC Code:
41116107
PubChem Substance ID:
329826594
NACRES:
NA.24

Key Documents

View All Documentation

Skip To

Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

grade

pharmaceutical primary standard

API family

testosterone

manufacturer/tradename

EDQM

drug control

USDEA Schedule IIIN; regulated under CDSA - not available from Sigma-Aldrich Canada

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

−20°C

SMILES string

CCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C

InChI

1S/C29H46O3/c1-4-5-6-7-8-9-10-11-27(31)32-26-15-14-24-23-13-12-21-20-22(30)16-18-28(21,2)25(23)17-19-29(24,26)3/h20,23-26H,4-19H2,1-3H3/t23-,24-,25-,26-,28-,29-/m0/s1

InChI key

LBERVHLCXUMDOT-MPZZESAYSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
Y0000696BP319T0250000
Testosterone decanoate European Pharmacopoeia (EP) Reference Standard

T0240000

Testosterone decanoate

Testosterone decanoate for system suitability European Pharmacopoeia (EP) Reference Standard

Y0000696

Testosterone decanoate for system suitability

Testosterone decanoate British Pharmacopoeia (BP) Reference Standard

BP319

Testosterone decanoate

Testosterone enantate European Pharmacopoeia (EP) Reference Standard

T0250000

Testosterone enantate

manufacturer/tradename

EDQM

manufacturer/tradename

EDQM

manufacturer/tradename

BP

manufacturer/tradename

EDQM

grade

pharmaceutical primary standard

grade

pharmaceutical primary standard

grade

pharmaceutical primary standard

grade

pharmaceutical primary standard

format

neat

format

neat

format

neat

format

neat

application(s)

pharmaceutical (small molecule)

application(s)

pharmaceutical (small molecule)

application(s)

pharmaceutical
pharmaceutical small molecule

application(s)

pharmaceutical (small molecule)

API family

testosterone

API family

testosterone

API family

testosterone

API family

testosterone

drug control

USDEA Schedule IIIN; regulated under CDSA - not available from Sigma-Aldrich Canada

drug control

-

drug control

-

drug control

-

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Testosterone decanoate EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

comparable product

Product No.
Description
Pricing

related product

Product No.
Description
Pricing

T0100000

Testosterone, European Pharmacopoeia (EP) Reference Standard

T0250000

Testosterone enantate, European Pharmacopoeia (EP) Reference Standard

T0300000

Testosterone propionate, European Pharmacopoeia (EP) Reference Standard

T0210000

Testosterone caproate, European Pharmacopoeia (EP) Reference Standard

T0260000

Testosterone isocaproate, European Pharmacopoeia (EP) Reference Standard

Y0000716

Testosterone isocaproate for system suitability, European Pharmacopoeia (EP) Reference Standard

Y0001312

Testosterone enantate for peak identification, European Pharmacopoeia (EP) Reference Standard

Y0001317

Testosterone enantate for system suitability, European Pharmacopoeia (EP) Reference Standard

Y0001313

Testosterone enantate impurity H, European Pharmacopoeia (EP) Reference Standard

Y0001409

Testosterone propionate for system suitability, European Pharmacopoeia (EP) Reference Standard

1649007

Testosterone propionate, United States Pharmacopeia (USP) Reference Standard

1647001

Testosterone cypionate, United States Pharmacopeia (USP) Reference Standard

1648004

Testosterone enanthate, United States Pharmacopeia (USP) Reference Standard

1646031

Testosterone Related Compound C, United States Pharmacopeia (USP) Reference Standard

1646097

Testosterone Related Compound I, United States Pharmacopeia (USP) Reference Standard

BP702

Testosterone propionate, British Pharmacopoeia (BP) Reference Standard

1646010

Testosterone Related Compound A CIII, United States Pharmacopeia (USP) Reference Standard

BP319

Testosterone decanoate, British Pharmacopoeia (BP) Reference Standard

BP321

Testosterone isocaproate, British Pharmacopoeia (BP) Reference Standard

BP1076

Testosterone, British Pharmacopoeia (BP) Reference Standard

1647012

Testosterone Cypionate Related Compound A, United States Pharmacopeia (USP) Reference Standard

PHR2026

Testosterone Propionate, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2027

Testosterone, Pharmaceutical Secondary Standard; Certified Reference Material

1647023

Testosterone Cypionate Related Compound B, United States Pharmacopeia (USP) Reference Standard

Y0002163

Testosterone for ID and assay, CRS, European Pharmacopoeia (EP) Reference Standard

Y0002174

Testosterone for system suitability A, CRS, European Pharmacopoeia (EP) Reference Standard

Y0002145

Testosterone impurity I, CRS, European Pharmacopoeia (EP) Reference Standard

PHR9196

5α-Androstan-17β-ol-3-one, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland

signalword

Danger

Hazard Classifications

Acute Tox. 4 Oral - Aquatic Acute 1 - Carc. 2 - Repr. 1B

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

J C do Prado et al.
Parasitology research, 85(10), 826-829 (1999-09-24)
Effects of orchiectomy on male Calomys callosus infected with the Y strain of Trypanosoma cruzi were studied. Male C. callosus of the same age and weight were divided into three groups: intact, sham operated, and castrated. After 1 month they
R W Hamill et al.
Brain research, 299(2), 331-337 (1984-05-14)
The effects of the hormone testosterone on neurotransmitter synthesis in peripheral sympathetic ganglia were examined in adult male Sprague-Dawley rats. Tyrosine hydroxylase (T-OH), the rate limiting enzyme in catecholamine biosynthesis was examined in the hypogastric (HG), coeliac (CG), and superior
H A Verheul et al.
Immunopharmacology, 11(2), 93-99 (1986-04-01)
Nandrolone decanoate injections (20, 40 or 80 mg/kg/3 weeks) in female or castrated male New Zealand black/white mice, starting at various ages (4, 9, 17 or 26 weeks) prolong survival, reduce proteinuria and affect the weights of various endocrine and
G Haidl et al.
Der Urologe. Ausg. A, 47(12), 1555-1556 (2008-11-18)
Evidence-based drug therapy for male infertility is often difficult because 30% of all cases of male infertility are classified as idiopathic, and another 30% need surgical treatment. Without knowledge of the underlying pathology, there is no foundation for a specific
B M Brady et al.
Human reproduction (Oxford, England), 21(1), 285-294 (2005-09-21)
The combination of etonogestrel implants with injectable testosterone decanoate was investigated as a potential male contraceptive. One hundred and thirty subjects were randomly assigned to three treatment groups, all receiving two etonogestrel rods (204 mg etonogestrel) and 400 mg testosterone
View All Related Papers

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service